Saving the Developing Brain: Implementing the Evidence-Based MOUD for Adolescents-View Presentation Slides

View Presentation Slides

Pdf Summary

This webinar, “Saving the Developing Brain: Implementing the Evidence-Based MOUD for Adolescents,” by Jose Vito, MD, focuses on the urgent need to treat adolescent opioid use disorder (OUD) with medications, especially in the era of fentanyl. It highlights a sharp rise in adolescent overdose deaths from 2019 to 2022, with fentanyl involved in most recent fatalities, often through counterfeit pills bought on social media. Despite this crisis, treatment access remains very limited: fewer than 1 in 10 youth with OUD receive medications, while many are offered detox or therapy alone.<br /><br />The presentation explains that adolescents are not “small adults.” Their brains are still developing, with reward pathways maturing before impulse control systems, increasing vulnerability to substance use and addiction. The talk emphasizes that OUD is a chronic brain disease, not a moral failing.<br /><br />It strongly argues that detoxification alone is not treatment because it does not address relapse risk, tolerance loss, or overdose mortality. Instead, medication for opioid use disorder (MOUD) is the standard of care, recommended by major professional organizations. The main FDA-approved options are buprenorphine, methadone, and extended-release naltrexone. Buprenorphine is presented as the first-line choice for most adolescents because it is safer, can be prescribed in office settings, reduces cravings and withdrawal, and improves retention. Methadone is effective but more restricted and harder for adolescents to access. Naltrexone requires complete detoxification first, which is often difficult for youth.<br /><br />The webinar provides practical guidance for starting buprenorphine, including withdrawal assessment, dosing, caregiver involvement, and the possibility of long-acting injectable formulations for adherence support. It also addresses common barriers such as stigma, family fears, provider discomfort, and fragmented systems of care.<br /><br />Key takeaways: screen routinely for OUD, offer MOUD, treat co-occurring mental health conditions, engage families, coordinate care, and reduce stigma.

Keywords

adolescent opioid use disorder

fentanyl crisis

medication for opioid use disorder

buprenorphine

methadone

extended-release naltrexone

overdose prevention

brain development

detoxification

stigma reduction